QSimulate is a Boston-based technology company focused on applying quantum simulation to problems in drug discovery and broader industrial R&D. Its core offering is a cloud-based platform that models molecular interactions with quantum-level precision, helping researchers optimize leads, especially covalent drug molecules and compounds interacting with metal ions. In November 2025 the firm released QUELO v2.3, adding enhanced sampling techniques and support for larger molecules and peptide drugs. Current collaborations span multinational enterprises such as Google, Mitsui, and JT Pharma, underscoring early commercial traction. The company plans to use newly raised capital to scale operations and broaden its platform’s capabilities to meet growing partner demand. Led by CEO Toru Shiozaki, QSimulate has secured $11 million in total funding to date.

Total raised

$14M

Funding rounds

2

Latest round

Seed

Latest activity

Nov 2025